Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Influenza
Clinical trial register · China

Influenza Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19224 matching records held by the registry are in this view. Synced 11 Nov 2026, 03:17 UTC
19224
Studies in scope
all four open statuses
11811
Recruiting now
open to new participants
2030
Lead sponsors
across recruiting studies
Top sites
Beijing 5 Wuhan 3 Shanghai 1 Shiyan 1 Xiangyang 1
Narrow the registerReset
Recruitment status
Phase
Site location
Beijing5 Wuhan3 Shanghai1 Shiyan1 Xiangyang1
All 14 locations
Target enrolment
to

Influenza trials in China

17 of 19224 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Effect of MxA Guidance on Antiviral Treatment in Respiratory Viral Infections
NCT07892872Respiratory Viral Infections, Influenza, SARS CoV 2 Infection
Capital Medical University
Not applicable
618
Beijing
2026-11-30
Active, closed
Ab&B Bio-tech Co., Ltd.JS
Phase 4
138
Shaoxing
2026-10-10
Recruiting
Abbott ID NOW Point-of-Care Testing
NCT07846423Influenza, Influenza-like Illness
China Medical University Hospital
Not applicable
1,080
2026-10-01
Not yet open
Sinovac Biotech Co., Ltd
Phase 4
150
Changsha, Chengdu, Chongqing, Guangzhou, Nanjing, Wuhan
2026-10
By invitation
Smart Analysis and Decision-Making for Emerging Infectious Diseases
NCT07678619Emerging Infectious Diseases, COVID-19, Influenza, Mpox (Monkeypox)
Peking University
Not applicable
108
Beijing
2026-08-10
Not yet open
Far East Bio-Tec Co., Ltd
Phase 2
196
2026-05-31
By invitation
Changchun BCHT Biotechnology Co.
Phase 4
200
Hohhot
2026-04-09
Not yet open
Tsinghua University
Observational
30
Beijing
2026-03
Not yet open
Shanghai Institute Of Biological Products
Phase 2
1,200
Wuhan
2026-01-07
Recruiting
Shanghai Institute Of Biological Products
Phase 1
120
Wuhan
2025-12-16
Recruiting
Capital Medical University
Phase 3
384
Beijing
2025-11-28
Active, closed
Ab&B Bio-tech Co., Ltd.JS
Phase 1
80
Shiyan
2025-11-13
Active, closed
Ab&B Bio-tech Co., Ltd.JS
Phase 1
80
Xiangyang
2025-11-13
Active, closed
Jiangsu Province Centers for Disease Control and Prevention
Phase 4
60
Lianyungang
2025-10-12
Not yet open
Capital Medical University
Not applicable
372
Beijing
2025-01-05
Recruiting
Jiangxi Qingfeng Pharmaceutical Co. Ltd.
Phase 3
748
Hanzhou
2024-12-01
Rows per page Showing 1–17 of 17
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 November 2026. https://priyalifescience.com/clinical-trials-china/condition/influenza

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,224 studies in total at the last sync on 11 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 17 of those studies listing the condition Influenza.

How many Influenza trials are recruiting in China?

5 of the 17 studies on this page are recruiting new participants as of the 11 Nov 2026, 03:17 UTC sync. A further 6 have not yet opened recruitment, 4 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Influenza), 17 studies
PhaseStudiesRecruitingShare
Not applicable4123.5%
Phase 44023.5%
Phase 13117.6%
Phase 33317.6%
Phase 22011.8%
Observational105.9%

Most active sponsors

Lead sponsors with the most studies (Influenza)
Lead sponsorStudiesRecruiting
Ab&B Bio-tech Co., Ltd.JS30
Capital Medical University31
Shanghai Institute Of Biological Products21
Changchun BCHT Biotechnology Co.10
China Medical University Hospital11
Far East Bio-Tec Co., Ltd10
Jiangsu Province Centers for Disease Control and Prevention10
Jiangxi Qingfeng Pharmaceutical Co. Ltd.11
Peking University10
Ruijin Hospital11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.